BIRC5 and cancer: As the administration of DA‐L‐DSA was found to increase the influx of cytotoxic T cells and decrease Tregs in various cancers expressing survivin, it was further investigated whether the DA‐L‐DSA treatment can improve the response rate of immune checkpoint inhibitors by overcoming the limited response rate of existing immune checkpoint inhibitors.